Search research articles
Contact Us
Filters
Showing results (1-10 of 80) with videos related to
Page
of 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2016
Imaging Hypoxia with ¹⁸F-Fluoromisonidazole: Challenges in Moving to a More Complicated Analysis
Mark Muzi, Kenneth A Krohn
Seminars in Oncology
|
June 12, 2008
Novel imaging approaches to head and neck cancer
Kenneth A Krohn, Bevan Yeuh
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2013
Standards for reporting PET clinical trials
Janet F Eary, Kenneth A Krohn
Seminars in Nuclear Medicine
|
February 24, 2015
F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy
Joseph G Rajendran, Kenneth A Krohn
Radiologic Clinics of North America
|
February 8, 2005
Imaging hypoxia and angiogenesis in tumors
Joseph G Rajendran, Kenneth A Krohn
Nuclear Medicine and Biology
|
April 26, 2020
Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation
Kenneth A Krohn, David R Vera
Nuclear Medicine and Biology
|
December 31, 2003
Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple
Kenneth A Krohn, Jeanne M Link
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2007
What is in a number? The FDG lumped constant in the rat brain
Kenneth A Krohn, Mark Muzi, Alexander M Spence
Molecular Imaging and Biology
|
November 25, 2003
Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method?
David A Mankoff, Mark Muzi, Kenneth A Krohn
Radiologic Clinics of North America
|
February 8, 2005
PET imaging of cellular proliferation
David A Mankoff, Anthony F Shields, Kenneth A Krohn
Page
of 8
Search research articles
Search
Showing results (1-10 of 80) with videos related to
Sort By:
Page
of 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2016
Imaging Hypoxia with ¹⁸F-Fluoromisonidazole: Challenges in Moving to a More Complicated Analysis
Mark Muzi, Kenneth A Krohn
Seminars in Oncology
|
June 12, 2008
Novel imaging approaches to head and neck cancer
Kenneth A Krohn, Bevan Yeuh
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2013
Standards for reporting PET clinical trials
Janet F Eary, Kenneth A Krohn
Seminars in Nuclear Medicine
|
February 24, 2015
F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy
Joseph G Rajendran, Kenneth A Krohn
Radiologic Clinics of North America
|
February 8, 2005
Imaging hypoxia and angiogenesis in tumors
Joseph G Rajendran, Kenneth A Krohn
Nuclear Medicine and Biology
|
April 26, 2020
Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation
Kenneth A Krohn, David R Vera
Nuclear Medicine and Biology
|
December 31, 2003
Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple
Kenneth A Krohn, Jeanne M Link
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2007
What is in a number? The FDG lumped constant in the rat brain
Kenneth A Krohn, Mark Muzi, Alexander M Spence
Molecular Imaging and Biology
|
November 25, 2003
Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method?
David A Mankoff, Mark Muzi, Kenneth A Krohn
Radiologic Clinics of North America
|
February 8, 2005
PET imaging of cellular proliferation
David A Mankoff, Anthony F Shields, Kenneth A Krohn
Page
of 8